📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Interactions between live attenuated influenza vaccine and nasopharyngeal microbiota among children aged 24-59 months in The Gambia: a phase 4, open-label, randomised controlled trial. (2025)

First Author: Peno C

Attributed to: Optimising Innate Host Defence to Combat Antimicrobial Resistance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.lanmic.2024.100971

PubMed Identifier: 39832517

Publication URI: http://europepmc.org/abstract/MED/39832517

Type: Journal Article/Review

Parent Publication: The Lancet. Microbe

ISSN: 2666-5247